RxDoctor Payments DataLook up a doctor →

Lynne Glaser

Nurse Practitioner · Cumberland, RINPI 1275520694

Payments from drug & device makers

$17,137in general payments, 2019–2025

Across 827 payments — averaging $20.72 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$2K
  • AstraZeneca$2K
  • Amgen$1K
  • Teva Pharmaceuticals USA, Inc.$1K
  • Pfizer$1K
  • Otsuka America Pharmaceutical, Inc.$955
  • plus $9K from 51 others

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie89$1,793
AstraZeneca59$1,593
Amgen53$1,288
Teva Pharmaceuticals USA, Inc.92$1,131
Pfizer57$1,076
Otsuka America Pharmaceutical, Inc.33$955
Vanda Pharmaceuticals Inc.30$699
Neurocrine Biosciences, Inc.37$651
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)30$628
Avanir Pharmaceuticals, Inc.20$601
Johnson & Johnson30$494
Boehringer Ingelheim18$467
E.r. Squibb & Sons, L.L.C.25$425
Alkermes, Inc.17$373
Lilly USA, LLC16$365
GSK6$309
Novartis16$286
Novo Nordisk10$276
Gilead13$274
Bayer9$254
Astellas Pharma US Inc14$249
Phathom Pharmaceuticals, Inc.15$246
Abbott7$214
Nestle Healthcare Nutrition Inc.22$210
Exact Sciences9$199
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC12$196
Mylan Specialty L.p.7$181
Amarin Pharma, Inc.11$166
Axsome Therapeutics, Inc.5$164
Takeda Pharmaceuticals U.S.A., Inc.7$139
CMP Pharma, Inc.5$116
Idorsia Pharmaceuticals US Inc5$106
Acadia Pharmaceuticals Inc1$104
Inspire Medical Systems, Inc.4$102
Merck5$95
Eisai Inc.5$91
Sumitomo Pharma America, Inc.4$84
Kowa Pharmaceuticals America, Inc.5$77
Esperion Therapeutics, Inc.4$71
Biohaven Pharmaceutical Holding Company Ltd.2$41
Ardelyx, Inc.2$39
Aimmune Therapeutics, Inc.1$26
UCB, Inc.1$25
Biogen1$22
Verona Pharma, Inc.1$22
Lundbeck LLC1$22
Dexcom, Inc.1$22
Boston Scientific1$21
Urovant Sciences Inc1$20
Insightec,inc1$20
Hikma Pharmaceuticals USA1$18
Indivior Inc.1$18
Alnylam Pharmaceuticals Inc.1$17
IBSA Pharma Inc.1$15
Cequr Corporation1$14
Bausch Health US, LLC1$14
Paratek Pharmaceuticals, Inc.1$12

How this compares

$17,137 in reported general payments places this provider in the 95th percentile of 396 nurse practitioner providers in Rhode Island.

See all nurse practitioner providers in Rhode Island →

Medicare billing

Part B allowed, 2024
$59,070
Medicare patients
234
Services billed
771

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other nurse practitioner in Cumberland

See the full list for Rhode Island →

Where these figures come from

Is this you, or does something look wrong? →